Risankizumab in the Management of Psoriasis in Solid Organ Transplant Recipients
        Saved in:
      
    
          | Main Authors: | M. Luz, A.M. Lé, T. Torres | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Elsevier
    
        2024-11-01 | 
| Series: | Actas Dermo-Sifiliográficas | 
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0001731024000541 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    [Artículo traducido] Risankizumab en el tratamiento de la psoriasis en pacientes trasplantados        
                          
 by: M. Luz, et al.
 Published: (2024-11-01)
- 
                
                    Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis        
                          
 by: April W. Armstrong, et al.
 Published: (2024-10-01)
- 
                
                    Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens        
                          
 by: B. J. Edwards, et al.
 Published: (2011-01-01)
- 
                
                    Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study)        
                          
 by: Diego Orsini, et al.
 Published: (2024-12-01)
- 
                
                    Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy        
                          
 by: Federico Pirro, et al.
 Published: (2025-01-01)
 
       